IN2015KN00091A - - Google Patents

Info

Publication number
IN2015KN00091A
IN2015KN00091A IN91KON2015A IN2015KN00091A IN 2015KN00091 A IN2015KN00091 A IN 2015KN00091A IN 91KON2015 A IN91KON2015 A IN 91KON2015A IN 2015KN00091 A IN2015KN00091 A IN 2015KN00091A
Authority
IN
India
Prior art keywords
tissue
dehydrated
humans
animals
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Carlo Terruzzi
Luca Degrassi
Original Assignee
Giellepi S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giellepi S P A filed Critical Giellepi S P A
Publication of IN2015KN00091A publication Critical patent/IN2015KN00091A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
IN91KON2015 2012-06-20 2013-06-20 IN2015KN00091A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001076A ITMI20121076A1 (it) 2012-06-20 2012-06-20 Composizione per uso locale nel trattamento del danno tissutale
PCT/IB2013/055066 WO2013190496A2 (en) 2012-06-20 2013-06-20 Composition and formulation for topical treatment of inflammation and tissue damage

Publications (1)

Publication Number Publication Date
IN2015KN00091A true IN2015KN00091A (pt) 2015-07-31

Family

ID=46466706

Family Applications (1)

Application Number Title Priority Date Filing Date
IN91KON2015 IN2015KN00091A (pt) 2012-06-20 2013-06-20

Country Status (8)

Country Link
US (1) US20150320838A1 (pt)
EP (1) EP2863928A2 (pt)
JP (1) JP2015520223A (pt)
CN (1) CN104640552A (pt)
IN (1) IN2015KN00091A (pt)
IT (1) ITMI20121076A1 (pt)
RU (1) RU2015101485A (pt)
WO (1) WO2013190496A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101979358B1 (ko) * 2017-01-03 2019-05-15 서울대학교산학협력단 소 유방염 치료제 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
WO1997035595A1 (en) 1996-03-26 1997-10-02 Dcv Biologics L.P. Egg anti-inflammatory composition, method of isolation and use
AU2372400A (en) * 1999-01-19 2000-08-07 Dcv, Inc. Egg anti-inflammatory composition and method of treating and preventing inflammation
US6706267B1 (en) * 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
CA2384246A1 (en) * 1999-09-14 2001-03-22 Orn Adalsteinsson Glucosamine and egg reducing inflammation
AU2001260794A1 (en) * 2000-05-23 2001-12-03 N.V. Nutricia Use of egg white and egg white fractions for tissue regeneration
FR2810550B1 (fr) 2000-06-27 2004-10-08 Medibrevex Nouvelle formes galeiques solubles d'oeufs de caille a usage medicamenteux pour lavage oculaire et nasale et leurs procedes de fabrication
RU2191551C1 (ru) 2001-07-05 2002-10-27 Волков Александр Григорьевич Способ лечения неосложненных фронтитов
JP5184726B2 (ja) * 2001-10-16 2013-04-17 帝國製薬株式会社 グルコサミン含有パップ剤
US20030125303A1 (en) * 2001-12-28 2003-07-03 Andrew Kucharchuk Transdermal formulation for repair and maintenance of connective tissue
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
JP4256125B2 (ja) * 2002-08-05 2009-04-22 ロート製薬株式会社 外用組成物
US20050053564A1 (en) * 2003-09-04 2005-03-10 Chaim Lieberman Use a plant extract to enhance hair growth and hair restoration for damaged hair
WO2005097069A1 (en) * 2004-03-26 2005-10-20 Stiefel Laboratories, Inc. Topical skin protectant cosmetic compositions
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
WO2008048076A1 (en) * 2006-10-20 2008-04-24 Amorepacific Corporation A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
JP5158436B2 (ja) * 2008-09-18 2013-03-06 国立大学法人 鹿児島大学 抗菌剤およびその製造方法、化粧料ならびに医薬品

Also Published As

Publication number Publication date
WO2013190496A3 (en) 2014-02-27
RU2015101485A (ru) 2016-08-10
ITMI20121076A1 (it) 2013-12-21
WO2013190496A2 (en) 2013-12-27
US20150320838A1 (en) 2015-11-12
JP2015520223A (ja) 2015-07-16
EP2863928A2 (en) 2015-04-29
CN104640552A (zh) 2015-05-20

Similar Documents

Publication Publication Date Title
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
BR112015002933A2 (pt) dispositivo implantável para uso no corpo humano e/ou animal para substituir uma válvula de um órgão.
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
CU20120161A7 (es) 5-fluoro-1h-pirazolopiridinas sustituidas
GB201709419D0 (en) Compositions, formulations and methods for treating ocular diseases
EA201391536A1 (ru) Противомикробные соединения и способы их получения и применения
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
UY35652A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
BR112018069682A2 (pt) métodos de tratamento para doenças colestáticas e fibróticas
EP2708551A4 (en) PEPTIDES WITH ANTIMICROBIAL ACTIVITY, THERAPEUTIC AND PROPHYLACTIC THERAPEUTIC DRUG COMPOSITIONS, COMPOSITIONS FOR THERAPEUTIC AND PROPHYLACTIC USE, USES THEREOF, AND USES OF PAENIBACILLUS EXTRACT
EP3344233A4 (en) TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF DOXYCLYCLIN AND THEIR USE IN THE TREATMENT OF DOXYCLYCLIN-RELATED ILLNESSES AND SUFFERING
IN2015KN00091A (pt)
UY37671A (es) N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso
EA201690574A1 (ru) Применение пидотимода в лечении заболеваний, связанных с воспалением
WO2015200601A3 (en) Lymphangiogenesis inhibitors for cancer and for graft survival
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
WO2015003049A3 (en) Compositions and methods to treat inflammatory joint disease
MX360885B (es) Nuevas composiciones antifungicas.
PH12020500472A1 (en) Autotaxin inhibitor compounds